Anti-CD3 antibodies and methods of use thereof

Details for Australian Patent Application No. 2005250499 (hide)

Owner NovImmune S.A.

Inventors Dean, Yann; Mach, Bernard; Leger, Olivier; Fischer, Nicolas; Elson, Greg Christopher Andrew; Kosco-Vilbois, Marie

Agent Cullens

Pub. Number AU-B-2005250499

PCT Pub. Number WO2005/118635

Priority 60/576,483 03.06.04 US; 60/609,153 10.09.04 US

Filing date 3 June 2005

Wipo publication date 15 December 2005

Acceptance publication date 8 December 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/118635 Priority application(s): WO2005/118635

8 December 2011 Application Accepted

  Published as AU-B-2005250499

5 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005250500-Disposable bioreactor systems and methods

2005250495-Identification of tumors